Ezetimibe; More Than a Low Density Lipoprotein Cholesterol Lowering Drug? An Update After 4 Years

E-ISSN： 1875-6212|9|1|62-86

ISSN： 1570-1611

Source： Current Vascular Pharmacology, Vol.9, Iss.1, 2011-01, pp. : 62-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipid Lowering Agents and the Endothelium: An Update after 4 Years

Current Vascular Pharmacology, Vol. 10, Iss. 1, 2012-01 ,pp. : 33-41

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Reducing Cardiovascular Risk: Is Low-Density Lipoprotein-Cholesterol (LDL-C) Lowering Enough? ]

Current Vascular Pharmacology, Vol. 10, Iss. 2, 2012-03 ,pp. : 173-177

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoprotein(a) Interactions With Low‐Density Lipoprotein Cholesterol and Other Cardiovascular Risk Factors in Premature Acute Coronary Syndrome (ACS)

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 5, Iss. 4, 2016-04 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS

By Chen Mei-Jou Yang Wei-Shiung Yang Jehn-Hsiahn Hsiao Chuhsing Kate Yang Yu-Shih Ho Hong-Nerng

Human Reproduction, Vol. 21, Iss. 9, 2006-09 ,pp. : 2266-2271

Oxford University Press

Access to resources Recommend Favorite

Dipeptidyl‐Peptidase‐4 Inhibitor, Alogliptin, Attenuates Arterial Inflammation and Neointimal Formation After Injury in Low‐Density Lipoprotein (LDL) Receptor‐Deficient Mice

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 3, 2015-03 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite